Application 020220

Type
NDA
Sponsor
BAYER HLTHCARE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ULTRAVIST 370IOPROMIDEINJECTABLE;INJECTION76.9%YesYes
002ULTRAVIST 300IOPROMIDEINJECTABLE;INJECTION62.3%YesYes
003ULTRAVIST 240IOPROMIDEINJECTABLE;INJECTION49.9%YesNo
004ULTRAVIST 150IOPROMIDEINJECTABLE;INJECTION31.2%YesNo
005ULTRAVIST 300 IN PLASTIC CONTAINERIOPROMIDEINJECTABLE;INJECTION62.3%YesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
50419-342UltravistiopromideBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-342UltravistiopromideBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-342UltravistiopromideBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-342UltravistiopromideBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-344UltravistiopromideBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-344UltravistiopromideBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-344UltravistiopromideBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-344UltravistiopromideBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-344UltravistiopromideBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-344UltravistiopromideBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-344UltravistiopromideBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-344UltravistiopromideBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-346UltravistiopromideBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-346UltravistiopromideBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-346UltravistiopromideBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-346UltravistiopromideBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-346UltravistiopromideBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-346UltravistiopromideBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-346UltravistiopromideBayer HealthCare Pharmaceuticals Inc.NDACurrent
50419-346UltravistiopromideBayer HealthCare Pharmaceuticals Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
74558SUPPL 2023-06-21
74556SUPPL 2023-06-20
74387SUPPL 2023-05-26
74375SUPPL 2023-05-26
74077SUPPL 2023-04-27
74066SUPPL 2023-04-26
70254SUPPL2022-02-25
70215SUPPL2022-02-22
59565SUPPL2019-08-02
59548SUPPL2019-08-02
53866SUPPL2018-04-27
53823SUPPL2018-04-26
53600SUPPL2018-04-04
53599SUPPL2018-04-04
49181SUPPL2017-08-02
49149SUPPL2017-07-31
47960SUPPL2017-04-12
47885SUPPL2017-04-07
2183SUPPL2015-07-10
12328SUPPL2015-07-09
12327SUPPL2012-05-07
2182SUPPL2012-05-04
24594SUPPL2010-01-20
12326SUPPL2010-01-08
24593SUPPL2010-01-05
24592SUPPL2007-09-06
34386SUPPL2007-09-04
2181SUPPL2005-08-15
34385SUPPL2004-04-05
24591SUPPL2004-03-16
2180SUPPL2003-05-29